Twist Bioscience (TWST) Operating Margin: 2018-2025
Historic Operating Margin for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -30.23%.
- Twist Bioscience's Operating Margin rose 1232.00% to -30.23% in Q3 2025 from the same period last year, while for Sep 2025 it was -36.18%, marking a year-over-year increase of 3438.00%. This contributed to the annual value of -36.18% for FY2025, which is 3437.00% up from last year.
- Per Twist Bioscience's latest filing, its Operating Margin stood at -30.23% for Q3 2025, which was up 3.58% from -31.36% recorded in Q2 2025.
- Twist Bioscience's Operating Margin's 5-year high stood at -30.23% during Q3 2025, with a 5-year trough of -133.13% in Q4 2021.
- In the last 3 years, Twist Bioscience's Operating Margin had a median value of -64.92% in 2024 and averaged -63.67%.
- Per our database at Business Quant, Twist Bioscience's Operating Margin crashed by 3,100bps in 2021 and then spiked by 7,780bps in 2025.
- Over the past 5 years, Twist Bioscience's Operating Margin (Quarterly) stood at -133.13% in 2021, then skyrocketed by 5,086bps to -82.28% in 2022, then spiked by 1,657bps to -65.70% in 2023, then skyrocketed by 2,665bps to -39.05% in 2024, then surged by 1,232bps to -30.23% in 2025.
- Its last three reported values are -30.23% in Q3 2025, -31.36% for Q2 2025, and -44.79% during Q1 2025.